154 related articles for article (PubMed ID: 37176734)
1. The Clinical Significance of Serum Free Light Chains in Bladder Cancer.
Gudowska-Sawczuk M; Kudelski J; Olkowicz M; Młynarczyk G; Chłosta P; Mroczko B
J Clin Med; 2023 May; 12(9):. PubMed ID: 37176734
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Free Light Chains (FLCs) Synthesis in Response to Exposure to SARS-CoV-2.
Gudowska-Sawczuk M; Moniuszko-Malinowska A; Pączek S; Guziejko K; Chorąży M; Mroczko B
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232891
[TBL] [Abstract][Full Text] [Related]
3. Trial use of a polymethylmethacrylate membrane for the removal of free immunoglobulin light chains in dialysis patients.
Oshihara W; Nagao H; Megano H; Arai J; Koide M; Takada M
NDT Plus; 2010 May; 3(Suppl 1):i3-i7. PubMed ID: 27046285
[No Abstract] [Full Text] [Related]
4. Kappa Free Light Chains and IgG Combined in a Novel Algorithm for the Detection of Multiple Sclerosis.
Gudowska-Sawczuk M; Tarasiuk J; Kułakowska A; Kochanowicz J; Mroczko B
Brain Sci; 2020 May; 10(6):. PubMed ID: 32471086
[TBL] [Abstract][Full Text] [Related]
5. Effects of Long-Term Storage on Serum Free Light Chain Stability.
Hörber S; Klein R; Peter A
Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
[TBL] [Abstract][Full Text] [Related]
6. Free Immunoglobulin Light Chains in Patients with Tick-Borne Encephalitis: Before and after Treatment.
Gudowska-Sawczuk M; Czupryna P; Moniuszko-Malinowska A; Pancewicz S; Mroczko B
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209994
[TBL] [Abstract][Full Text] [Related]
7. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
[TBL] [Abstract][Full Text] [Related]
11. Free Light Chains
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298479
[TBL] [Abstract][Full Text] [Related]
12. Serum free light chain assessment in type 1 autoimmune pancreatitis.
Ikemune M; Uchida K; Tsukuda S; Ito T; Nakamaru K; Tomiyama T; Ikeura T; Naganuma M; Okazaki K
Pancreatology; 2021 Apr; 21(3):658-665. PubMed ID: 33741268
[TBL] [Abstract][Full Text] [Related]
13. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
Draborg AH; Lydolph MC; Westergaard M; Olesen Larsen S; Nielsen CT; Duus K; Jacobsen S; Houen G
PLoS One; 2015; 10(9):e0138753. PubMed ID: 26402865
[TBL] [Abstract][Full Text] [Related]
14. Serum free light chain reference values: a critical approach.
Altinier S; Seguso M; Zaninotto M; Varagnolo M; Adami F; Angeli P; Plebani M
Clin Biochem; 2013 May; 46(7-8):691-3. PubMed ID: 23384536
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma.
Basile U; Santini G; Napodano C; Macis G; Pocino K; Gulli F; Malerba M; Bush A; Adcock IM; Montuschi P
Front Pharmacol; 2023; 14():1126535. PubMed ID: 37397489
[No Abstract] [Full Text] [Related]
17. Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.
Gigante A; Pellicano C; Leodori G; Napodano C; Vantaggio L; Gulli F; Marino M; Visentini M; Rosato E; Basile U
Clin Exp Immunol; 2021 Aug; 205(2):135-141. PubMed ID: 33934349
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of determination of free light chains (Kappa and Lambda) in plasma and serum by Swedish laboratories as monitored by external quality assessment.
Rollborn N; Jakobsson J; Campbell A; Nordin G; Karlsson M; Larsson A; Kultima K
Clin Biochem; 2023 Jan; 111():47-53. PubMed ID: 36241061
[TBL] [Abstract][Full Text] [Related]
19. Effects of aerobic and resistance exercise for 9 months on serum free light chains in type 2 diabetes.
Kim Y; Campbell JP; Johannsen NM; Church TS; Cho E; Heaney J; Spielmann G
Front Physiol; 2024; 15():1328470. PubMed ID: 38725572
[No Abstract] [Full Text] [Related]
20. The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients.
Di Caprio R; Sacchelli L; Di Spigna G; Ricciardone M; Bardazzi F; Ladogana P; Scala E; Fabbrocini G; Covelli B; Balato A; Postiglione L
Eur J Dermatol; 2023 Feb; 33(1):12-18. PubMed ID: 37154810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
